Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carlo Tascini and Luca Quartuccio.
Carlo Tascini
Connection Strength
2.487
Luca Quartuccio
  1. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 2021 04; 140:155438.
    View in: PubMed
    Score: 0.924
  2. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444.
    View in: PubMed
    Score: 0.882
  3. Rev Rhum Ed Fr. 2021 Oct; 88(5):377-381.
    View in: PubMed
    Score: 0.236
  4. Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6. J Med Virol. 2020 11; 92(11):2852-2856.
    View in: PubMed
    Score: 0.223
  5. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine. 2020 10; 87(5):439-443.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.